NCT06308874View on ClinicalTrials.gov

Phase 1 to Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

February 17, 2023

Study Completion Date

February 17, 2023

Conditions
Non-alcoholic Steatohepatitis
Interventions
DRUG

Amg dose administration group

Orally, Amg tablet single administration

DRUG

Amg dose administration group- Placebo

Orally, Placebo Amg tablet single administration

DRUG

Bmg dose administration group

Orally, Bmg tablet single administration

DRUG

Bmg dose administration group- Placebo

Orally, Placebo Bmg tablet single administration

Trial Locations (1)

16684

J2H Biotech, Suwon

Sponsors

Lead Sponsor

J2H Biotech
All Listed Sponsors
lead

J2H Biotech

INDUSTRY